Dharini Shah

Company: Tidal (a Sanofi Company)

Job title: Senior Research Director, Immunology

Seminars:

Panel Discussion: Opportunities & Challenges to Optimize In Vivo RNA Engineering 10:30 am

Elucidating the opportunities for in vivo cell therapy to minimize current ex vivo bottlenecks and the role of RNA engineering in producing versatile therapies Achieving a transient vs. longer term effect for different indications with RNA modification Maintaining consistent in vivo production of RNA to yield long-term responsesRead more

day: Day Two

Sharing an Overview of Key Developments & Players in the RNA-Based CTx Space & the Future Prospectus 9:30 am

Providing a comprehensive overview of the preclinical pipeline of RNA-based CTx and revealed clinical trials Sharing insights into the different approaches, opportunities, and current trends to elucidate future direction for RNA-edited CTx Comparing the efficacy and safety of viral and non-viral delivery techniquesRead more

day: Day One